Publications

Last 15 CNLab publications:

1. Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation Saresella M, Zoia CP, La Rosa F, Bazzini C, Sala G, Grassenis E, Marventano I, Hernis A, Piancone F, Conti E, Sesana S, Re F, Seneci P, Ferrarese C, Clerici M. Pharmaceuticals, 2023 16 (12), art. no. 1725, DOI: 10.3390/ph16121725

2. Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer’s disease  Turri M., Conti E., Pavanello C., Gastoldi F., Palumbo M., Bernini F., Aprea V., Re F., Barbiroli A., Emide D., Galimberti D., Tremolizzo L., Zimetti F., Calabresi L., Andreoni S., Appollonio I., Da Re F., Ferrarese C., Karantzoulis A., Negro G., Pozzi F.E., Remoli G., Storti B., Zoia C.P. Alzheimer's Research and Therapy, 2023 15 (1), art. no. 95, DOI: 10.1186/s13195-023-01241-6

3. Glibenclamide-Loaded Nanoparticles Reduce NLRP3 Inflammasome Activation and Modulate miR-223-3p/miR-7-1-5p Expression in THP-1 Cells Mancuso R., Citterio L.A., Agostini S., Marventano I., La Rosa F., Re F., Seneci P., Saresella M., Clerici M. Pharmaceuticals,  2023 16 (11), art. no. 1590 DOI: 10.3390/ph16111590

4. SPRi analysis of molecular interactions of mApoE-functionalized liposomes as drug delivery systems for brain diseases Picciolini S., Rodà F., Gualerzi A., Mangolini V., Forleo L., Mangolini A., Sesana S., Antoniou A., Re F., Seneci P., Bedoni M. Analyst, 2023 148 (23), pp. 6070 - 6077 DOI: 10.1039/d3an01507f 

5. Roadmap on nanomedicine for the central nervous system Ciofani G., Campisi M., Mattu C., Kamm R.D., Chiono V., Raynold A.A.M., Freitas J.S., Redolfi Riva E., Micera S., Pucci C., Novio F., Lorenzo J., Ruiz-Molina D., Sierri G., Re F., Wunderlich H., Kumari P., Kozielski K.L., Chami M., Marino A., Ferreira L. JPhys Materials, 2023 6 (2), art. no. 022501, DOI: 10.1088/2515-7639/acab88

6. Raman Spectroscopy Characterization of Multi-Functionalized Liposomes as Drug-Delivery Systems for Neurological Disorders Rodà F., Picciolini S., Mangolini V., Gualerzi A., Seneci P., Renda A., Sesana S., Re F., Bedoni M. Nanomaterials, 2023, 13 (4), art. no. 699, DOI: 10.3390/nano13040699

7. Editorial: Delivering nucleic acids to immune and non-immune cells Afonin K.A., Re F., Boraschi D. Frontiers in Immunology, 2023, 14, art. no. 1237506 DOI: 10.3389/fimmu.2023.1237506

8. Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity Re F., Giorgetti S., Biondi B., Scapin S., Mantegazza F., Cassina V., Sesana S.M., Rizzi L., Eberini I., Palazzolo L., Beeg M., Gobbi M., Sardina M., Masserini M. Annals of Medicine, 2023, 55 (1), art. no. 2205659, DOI: 10.1080/07853890.2023.2205659

9. Dual Functionalized Liposomes for Selective Delivery of Poorly Soluble Drugs to Inflamed Brain Regions Giofrè S., Renda A., Sesana S., Formicola B., Vergani B., Leone B.E., Denti V., Paglia G., Groppuso S., Romeo V., Muzio L., Balboni A., Menegon A., Antoniou A., Amenta A., Passarella D., Seneci P., Pellegrino S., Re F. Pharmaceutics, 2022, 14 (11), art. no. 2402, DOI: 10.3390/pharmaceutics14112402

10. Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics Taiarol L, Bigogno C, Sesana S, (…), Dondio G, Steinkühler C, Re F. CANCERS, 2022  vol. 14, 2978 doi: 10.3390/cancers14122978 

11. TCR-engineered iNKT cells induce robust antitumor response by dual targeting cancer and suppressive myeloid cells Delfanti G., Cortesi F., Perini A., (…), Sesana S., Re F., Shen H., Dellabona P., Casorati G. SCIENCE IMMUNOLOGY 2022  vol. 7, p.1-18, doi: 10.1126/sciimmunol.abn6563 

12. H-Ferritin nanoparticle-mediated delivery of antibodies across a BBB in vitro model for treatment of brain malignancies. Rizzuto MA, Dal Magro R, Barbieri L, Pandolfi L, Sguazzini-Viscontini A, Truffi M, Salvioni L, Corsi F, Colombo M, Re F, Prosperi D. Biomater Sci. 2021 Feb 5. doi: 10.1039/d0bm01726d.

13. Oxidative Stress Boosts the Uptake of Cerium Oxide Nanoparticles by Changing Brain Endothelium Microvilli Pattern. Dal Magro R, Vitali A, Fagioli S, Casu A, Falqui A, Formicola B, Taiarol L, Cassina V, Marrano CA, Mantegazza F, Anselmi-Tamburini U, Sommi P, Re F. Antioxidants (Basel). 2021 Feb 9;10(2):266. doi: 10.3390/antiox10020266.

14. Post-Translational Modification Analysis of VDAC1 in ALS-SOD1 Model Cells Reveals Specific Asparagine and Glutamine Deamidation. Pittalà MGG, Reina S, Cubisino SAM, Cucina A, Formicola B, Cunsolo V, Foti S, Saletti R, Messina A. Antioxidants (Basel). 2020 Dec 2;9(12):1218. doi: 10.3390/antiox9121218.

15. An update of nanoparticle-based approaches for glioblastoma multiforme immunotherapy. Taiarol L, Formicola B, Magro RD, Sesana S, Re F. Nanomedicine (Lond). 2020 Aug;15(19):1861-1871. doi: 10.2217/nnm-2020-0132.